Pharmafile Logo

Glaucoma in perspective

- PMLiVE

Valeant begins search for new CEO

Michael Pearson will continue in the role until his successor is appointed

There’s never a dull moment at Lucid Group

Andrea Hamlin, Angela Tye-Galichet, Emma Herring and Ify Onyeaso were all treated to a fabulous lunch with the Lucid Co-Founders, Dennis O’Brien and Jan Steele in celebration of their 5...

Lucid Group Communications Limited

Lucid Group support local charity event

Lucid Group donated 75 Easter chocolate bunnies to a group of local school children organising an Easter Egg Hunt who were raising funds for Médecins Sans Frontières. The egg hunt...

Lucid Group Communications Limited

- PMLiVE

Apple creates open source personal health app software

Will release CareKit framework later in the Spring 

- PMLiVE

Amgen and UCB’s romosozumab hits goals in male osteoporosis

Firms will discuss data with regulators before planning a new male licence application

Novartis building

NICE backs Novartis’ Entresto for heart failure

But approves narrower indication than has been authorised by Scotland's SMC

- PMLiVE

Nicki Muir moves from LEC Healthcare to The Purple Agency

She joins as account director of its healthcare team

- PMLiVE

Using social data to see patients more clearly

A new dawn is approaching in healthcare and drug safety

Sanofi appoints Diane Souza and Thomas Südhof

They join the board as independent directors

- PMLiVE

Britain facing social care ‘time bomb’

Raising awareness of financial realities is key first step, Astellas Debate hears

- PMLiVE

Positive trials bring Pfizer closer to new use for Xeljanz

Rheumatoid arthritis drug performs in two ulcerative colitis trials

Celgene building

Wales backs NHS use of Abraxane despite NICE rejection

Overrules UK decision and will maintain access to Celgene’s pancreatic cancer drug

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links